FDA Drug Application (203326) for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE by ROXANE

Back to FDA Applications sponsored by ROXANE

Application Number203326
Product Number001
FormTABLET;SUBLINGUAL
DosageEQ 2MG BASE;EQ 0.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Active IngredientBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPRENORPHINE HYDROCHLORIDE9
List of drugs with Active Ingredient NALOXONE HYDROCHLORIDE12


Back to FDA Applications sponsored by ROXANE